About 40 percent of head and neck cancer survivors do not return to work

the ONA take:

According to a study published in the journal Head & Neck, researchers from Jena University Hospitial and University Medical Centre in Germany have found that many survivors of head and neck cancer do not return to work.

For the exploratory study, researchers identified 55 head and neck cancer survivors no older than 60 years of age.

All participants completed a survey that included subscales from various health questionnaires. Results showed that the rate of employed patients decreased from 75% of patients prior to diagnosis to 33% at an average of 66.8 months following diagnosis.

Researchers found that current employment was associated with more difficult physical work prior to diagnosis, surgical treatment, and current risky consumption of alcohol.

The study also showed that unemployed survivors reported decreased functional and social well-being scores and increased depression scores.

The findings suggest that psychosocial variables were significantly associated to employment, but the authors note that further research is necessary to evaluate these relationships.

About 40% of head and neck cancer survivors do not return to work
Many survivors of head and neck cancer do not return to work.
Many head and neck cancer survivors do not return to work, according to a study published in the April issue of Head & Neck.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs